Unknown

Dataset Information

0

Autologous non-human primate model for safety assessment of piggyBac transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor.


ABSTRACT: Objectives:Chimeric antigen receptor (CAR)-T cell therapy redirected to specific antigens on tumor cells is a promising immunotherapy strategy for various cancers. Most target antigens are also expressed on normal tissues at varying levels, and therefore, a considerable challenge in the field is determining safety profiles, including life-threatening off-tumor and off-target toxicities. The granulocyte-macrophage colony-stimulating factor receptor (hGMR) is a promising target for CAR T-cell therapy for a subset of acute myelocytic leukaemia, although it is also expressed on normal cells including monocytes, macrophages, CD34-positive haematopoietic cells and vascular endothelial cells. hGMR and other immune-related proteins are highly conserved between humans and cynomolgus macaques (Macaca fascicularis). Therefore, in this study, we engineered cynomolgus T cells to express CAR molecules redirected to hGMR by piggyBac (PB) transposon-based gene transfer and adoptively transferred autologous hGMR-CAR T cells into cynomolgus macaques. Methods:We established PB-mediated human GMR (hGMR)-specific CAR T cells using cynomolgus peripheral blood mononuclear cells and transferred them into autologous individuals, and evaluated the potential toxicity related to hGMR-CAR T cells. Results:hGMR-CAR T cells did not exert overt organ toxicities such as bone marrow suppression, monocytopenia and vasculitis, although they recognised and killed cynomolgus monocytes and macrophages in vitro. Conclusion:Although our model did not simulate a tumor-bearing model, it supports the safety of hGMR-CAR T cells and demonstrates the usefulness of a non-human primate model to evaluate the safety of T-cell products by assessing off-tumor/off-target toxicity before clinical trials.

SUBMITTER: Morokawa H 

PROVIDER: S-EPMC7680920 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Autologous non-human primate model for safety assessment of <i>piggyBac</i> transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor.

Morokawa Hirokazu H   Yagyu Shigeki S   Hasegawa Aiko A   Tanaka Miyuki M   Saito Shoji S   Mochizuki Hidemi H   Sakamoto Kengo K   Shimoi Akihito A   Nakazawa Yozo Y  

Clinical & translational immunology 20201122 11


<h4>Objectives</h4>Chimeric antigen receptor (CAR)-T cell therapy redirected to specific antigens on tumor cells is a promising immunotherapy strategy for various cancers. Most target antigens are also expressed on normal tissues at varying levels, and therefore, a considerable challenge in the field is determining safety profiles, including life-threatening off-tumor and off-target toxicities. The granulocyte-macrophage colony-stimulating factor receptor (hGMR) is a promising target for CAR T-c  ...[more]

Similar Datasets

| S-EPMC3615126 | biostudies-literature
| S-EPMC5935005 | biostudies-literature
| S-EPMC10127946 | biostudies-literature
| S-EPMC4506240 | biostudies-literature
| S-EPMC5916331 | biostudies-literature
| S-EPMC3852053 | biostudies-literature
| S-EPMC5784476 | biostudies-literature
| S-EPMC3707315 | biostudies-literature
| S-EPMC5926922 | biostudies-literature